FDA approves Spravato, first monotherapy nasal spray to treat depression
-
The Food and Drug Administration has approved the first-ever stand-alone
nasal spray to treat drug-resistant depression. Johnson & Johnson's
Spravato was ...
18 minutes ago
No comments:
Post a Comment